BrainGain Sweden is a collaborative effort compiled by a host of national stakeholders from industry, academia and other organizations


Academia

University of Gothenburg (UGOT), Karolinska Institute (KI), Lund University (LU), Royal Institute of Technology (KTH), Uppsala University (UU), Umeå University (UMU) 

HEALTH CARE PROVIDERS

Region Skåne, Västra Götalandsregionen, Stockholm County Council, Uppsala County council

Swedish companies and associations

BioArctic Neuroscience AB, Bioservo Technologies, CBD Solutions AB, DanPet AB, Denator AB, Genepod AB, IRL – Integrative Research Laboratories Sweden AB, Karo Bio AB, Limulus AB, Medfield Diagnostics AB, NeuroVive Pharmaceutical AB, Read Glead Discovery AB, SARomics Biostructures AB, Tedroff Neuro Care AB, Qualisys AB, Quick Cool AB, Quixolabs AB, The Swedish Association of the Pharmaceutical Industry (LIF)

Research networks

BAGADILICO (Linnaeus environment for basal ganglia diseases LU), MultiPark (SRA at LU/UGOT), Neuronano Research Centre (Linnaeus environment, LU), SeRC (SRA within e-science at KTH, KI and SU, and LiU), the Stockholm Brain Institute, StratNeuro (SRA at KI/UMU), Swedish Brain Power (network of Swedish researchers in PD, AD and amyotrophic lateral sclerosis), SWEPAR-Net (network of Swedish university clinics and preclinical scientists that organizes clinical trials for PD at the national level), Uppsala Berzelii Techology Center of Neurodiagnostics (SRA at UU)

Other organizations

AlzeCure Foundation (non-profit research foundation), Swedish center for toxicological sciences (SweTox), The Swedish Brain Foundation

Patient organizations

Alzheimer Sweden, The Swedish Parkinson Association, The Swedish Stroke Association